Amarin Corp Plc (AMRN)

[sts66]

How is getting both V and GV on the same tier possible, let alone a "win" for AMRN? By definition a brand name can never be on the same tier as a generic - although an insurer might decide to make costs equal, but that is very difficult to do for a single drug because nearly all plans have a fixed single price for all generics - like Walmarts $3/scrip for any generic. Healthnet (and all other insurers) paying for GV for the CVD indication after a PA is supplied stating the scrip is for R-IT indication is infringement - AMRN is dead in the US if they give up on trying to prove that. Hell, they're probably dead anyway - how many years will it take for them to build up significant sales in the EU, and at what cost? They flooded Germany is 200 reps IIRC then had to take a huge writeoff to close down German operations when they refused to pay a reasonable price for V.